Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?

LT (Laura) Burgers; Sjoerd Nauta; Jaap Deckers; Hans Severens; Ken Redekop

doi:10.1016/j.ijcard.2014.08.134

Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?

LT (Laura) Burgers, Sjoerd Nauta, Jaap Deckers, Hans Severens, Ken Redekop

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	980-987
Number of pages	8
Journal	International Journal of Cardiology
Volume	176
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2014.08.134
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijcard.2014.08.134

http://hdl.handle.net/1765/39702

Cite this

@article{9c8480028f3d4229ba3b0503ef936a7b,

title = "Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?",

author = "Burgers, {LT (Laura)} and Sjoerd Nauta and Jaap Deckers and Hans Severens and Ken Redekop",

year = "2014",

doi = "10.1016/j.ijcard.2014.08.134",

language = "Undefined/Unknown",

volume = "176",

pages = "980--987",

journal = "International Journal of Cardiology",

issn = "0167-5273",